1. Home
  2. DSX vs ALLO Comparison

DSX vs ALLO Comparison

Compare DSX & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$1.66

Market Cap

220.0M

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.35

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
ALLO
Founded
1999
2017
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.0M
252.9M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
DSX
ALLO
Price
$1.66
$1.35
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$8.67
AVG Volume (30 Days)
578.1K
2.7M
Earning Date
11-20-2025
11-06-2025
Dividend Yield
2.41%
N/A
EPS Growth
231.99
N/A
EPS
0.15
N/A
Revenue
$218,560,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.40
$100.00
P/E Ratio
$11.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.86
52 Week High
$2.04
$3.78

Technical Indicators

Market Signals
Indicator
DSX
ALLO
Relative Strength Index (RSI) 38.39 47.06
Support Level $1.67 $1.30
Resistance Level $1.73 $1.52
Average True Range (ATR) 0.06 0.09
MACD -0.01 -0.02
Stochastic Oscillator 4.78 20.37

Price Performance

Historical Comparison
DSX
ALLO

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: